Definium Therapeutics (DFTX) Return on Equity [ROE] (2021 - 2026)
Definium Therapeutics' Return on Equity [ROE] came in at -36.71% for Q2 2026, up 23.38 percentage points from -60.09% a year earlier and up 24.66 percentage points from the prior quarter.
Powered by 
Analysis
Definium Therapeutics (DFTX) Return on Equity [ROE] (2021 - 2026) Analysis & Trends
For FY2025, Definium Therapeutics' Return on Equity [ROE] was -56.07%, up 3.16 percentage points from FY2024.
- Return on Equity [ROE] carries a five-year change of +28.10 percentage points (FY2020 to FY2025).
- Going back by year, Return on Equity [ROE] was -59.23% in FY2024 (+18.66 pp), -77.89% in FY2023 (-40.35 pp), -37.54% in FY2022 (+44.24 pp) and -81.78% in FY2021 (+2.39 pp).
- The Q2 2026 figure represents the highest quarterly Return on Equity [ROE] in data going back to Q4 2021.
- Year-over-year, Return on Equity [ROE] increased in four of the last eight quarters, with an average year-over-year change of +2.94 percentage points.
- The fastest year-over-year change in Return on Equity [ROE] over five years came in Q4 2024 (a gain of 64.88 percentage points), and the weakest in Q4 2023 (a drop of 65.13 percentage points).
- Business Quant data shows DFTX's Return on Equity [ROE] at -61.38% (Q1 2026), -69.50% (Q4 2025) and -91.99% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 25.32% |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | - |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 31.52% |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 4.97% |
| 10 | Definium Therapeutics | 3.93 Bn | 1.85 Bn | - | -36.71% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -36.71% |
| Mar 31, 2026 | -61.38% |
| Dec 31, 2025 | -69.50% |
| Sep 30, 2025 | -91.99% |
| Jun 30, 2025 | -60.09% |
| Mar 31, 2025 | -44.80% |
| Dec 31, 2024 | -37.58% |
| Sep 30, 2024 | -37.09% |
| Jun 30, 2024 | -42.47% |
| Mar 31, 2024 | -66.09% |
| Dec 31, 2023 | -102.47% |
| Sep 30, 2023 | -72.10% |
| Jun 30, 2023 | -58.26% |
| Mar 31, 2023 | -41.19% |
| Dec 31, 2022 | -37.34% |
| Sep 30, 2022 | -49.46% |
| Jun 30, 2022 | -53.18% |
| Mar 31, 2022 | -67.79% |
| Dec 31, 2021 | -58.95% |
API Access
Definium Therapeutics Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=DFTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "DFTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=DFTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();